NCT05750303 is a clinical trial in Ischemic Stroke, sponsored by Medical University of Lodz.

Who is sponsoring NCT05750303?

NCT05750303 is sponsored by Medical University of Lodz.

What condition does NCT05750303 study?

NCT05750303 studies Ischemic Stroke.

Is NCT05750303 still recruiting?

NCT05750303 is currently completed. Last updated 1 March 2023.

Last reviewed 2023-03-01 · How we verify

NCT05750303

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Potential Prognostic Markers of Recovery in Post-stroke Rehabilitation

Completed Last updated 1 March 2023

What this trial tests

trial in Ischemic Stroke in 32 participants. Completed in 31 January 2023.

Timeline

2 January 2022

Primary endpoint
31 January 2023

31 January 2023

Quick facts

Lead sponsor	Medical University of Lodz
Status	Completed
Study type	OBSERVATIONAL
Enrollment	32
Start date	2 January 2022
Primary completion	31 January 2023
Estimated completion	31 January 2023
Sites	1 location across Poland

Conditions studied

Ischemic Stroke — all drugs for Ischemic Stroke →

Sponsor

Medical University of Lodz

Who can join

18 and older, any sex, with Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite increasingly effective early treatment strategies for ischemic stroke, post-stroke recovery is often incomplete and depend on spontaneous and therapeutic-induced processes related to neuroplasticity, angiogenesis and reperfusion. These processes are regulated by growth factors, neurotrophines, neurotransmitters, hormones and other factors. This study aims to search biomarkers that prognose brain repair ability and consequently estimate an outcome of stroke patients. The prognostic value of proteins VEGF, IGF-1 and MMP-9 and expression of genes VEGF, IGF-1, MMP-9 is evaluated in association with clinical scales including cognitive assessment scales and depression scales. Blood sample collection as well as scales recording are taken at baseline and 3 weeks later after rehabilitation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Circulating Serum VEGF, IGF-1 and MMP-9 and Expression of Their Genes as Potential Prognostic Markers of Recovery in Post-Stroke Rehabilitation-A Prospective Observational Study.
Włodarczyk L, Cichoń N, Karbownik MS, Saso L, et al · · 2023 · cited 11× · PMID 37371326 · DOI 10.3390/brainsci13060846
Exploring the Role of MMP-9 and MMP-9/TIMP-1 Ratio in Subacute Stroke Recovery: A Prospective Observational Study.
Włodarczyk L, Cichon N, Karbownik MS, Saluk J, et al · · 2024 · cited 2× · PMID 38891934 · DOI 10.3390/ijms25115745

Verify or expand the search:

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting

Other Medical University of Lodz trials

Trials by the same sponsor.

NCT07391969 — Evaluation of SaCo VLMA for General Anesthesia for Laparoscopic Procedures · NA · not yet recruiting
NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting
NCT06850597 — Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's D · Phase 2 · recruiting
NCT06917300 — Virtual Reality as a Digital Premed to Alleviate Pain and Anxiety Preoperatively in Patients Undergoing Spine Surgery · NA · recruiting
NCT06391216 — The Effect of Probiotic Supplementation on Mental Health in Healthy Volunteers · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05750303 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Lodz
Last refreshed: 1 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05750303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing